Considering the complexity of pathways of folate metabolism and utilisations, the dose and timing of folate intake should be taken into consideration, and more prospective studies and intervention studies are necessary for further evaluation of the effects of folic acid fortification according to specific dietary habits or genetic background of different populations.
The albuterol utilisation was also converted to defined daily dose (DDD) [32], which was designed to standardise the dose between different types of formulation.
We observed significant reversions in the extent of glucose utilisation for ribose and fatty acid synthesis even at the lowest doses of CP-320626 well before significant increase in cell cycle arrest or apoptosis induction occurred.
To obtain detailed real-life data on costs and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in patients treated in Switzerland.
To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in rheumatoid arthritis (RA) patients treated in Germany.
This modulation can be achieved by blocking fatty acid entry into mitochondria (for example, using a carnitine palmitoyl transferase inhibitor such as perhexiline) or by enhancing utilisation of glucose through a high-dose glucose-insulin-potassium infusion.
Utilisation was measured in terms of Defined Daily Dose, with DDDs defined as ' the average maintenance dose of a drug when used in its major indication in adults', with this measure recognised as the international standard to assess utilisation patterns within and between countries [ 59]. 2012 DDDs were used in line with international guidance [ 59- 61].
However, to control for potential confounding effects, treatment utilisation as well as changes in the dose of antidepressant medication will be closely monitored during the study period.
Measurement units of utilisation are the number of prescriptions, defined daily doses and expenditures.
Potential cost savings were determined by comparing the cost of each of the five scenarios to continued PPI use (actual PPI utilisation in the HSE-PCRS pharmaclaimsims database).The price per dose unit for each PPI was calculated.
